LOGIN
The Use of Various Antithrombotic Agents for Venous Thromboembolism Prophylaxis After TKA
April 2023
The Use of Various Antithrombotic Agents for Venous Thromboembolism Prophylaxis After TKA
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Effectiveness of different antithrombotic agents in combination with tranexamic acid for venous thromboembolism prophylaxis and blood management after total knee replacement: a prospective randomized study.
BMC Musculoskelet Disord . 2023 Jan 4;24(1):5.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
One hundred and eighty patients undergoing primary unilateral total knee arthroplasty were randomized to receive either rivaroxaban (n=60), dalteparin sodium (n=60), or aspirin (n=60) once a day for 30 days. The primary outcomes of interest were drainage volume and thrombotic complication rates. Secondary outcomes of interest included platelet count, blood volume, transfusion rate, intraoperative ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Join the Conversation
Please Login or Join to leave comments.